Literature DB >> 27603000

Incidence of Depression After Stroke, and Associated Risk Factors and Mortality Outcomes, in a Large Cohort of Danish Patients.

Terese S H Jørgensen1, Ida K Wium-Andersen2, Marie K Wium-Andersen3, Martin B Jørgensen4, Eva Prescott5, Solvej Maartensson6, Per Kragh-Andersen7, Merete Osler1.   

Abstract

IMPORTANCE: More than 30 million people live with a stroke diagnosis worldwide. Depression after stroke is frequent, and greater knowledge of associated risk factors and outcomes is needed to understand the etiology and implications of this disabling complication.
OBJECTIVES: To examine whether the incidence of and risk factors for depression differ between patients with stroke and a reference population without stroke and to assess how depression influences mortality. DESIGN, SETTING, AND PARTICIPANTS: Register-based cohort study in Denmark. Participants were all individuals 15 years or older with a first-time hospitalization for stroke between January 1, 2001, and December 31, 2011 (n = 157 243), and a reference population (n = 160 236) matched on age, sex, and municipality. The data were analyzed between January and March 2016. MAIN OUTCOMES AND MEASURES: The incidence of depression and mortality outcomes of depression (defined by hospital discharge diagnoses or antidepressant medication use) were examined using Cox proportional hazards regression analyses.
RESULTS: In total, 34 346 patients (25.4%) with stroke and 11 330 (7.8%) in the reference population experienced depression within 2 years after study entry. Compared with the reference population, patients with stroke had a higher incidence of depression during the first 3 months after hospitalization (hazard ratio for stroke vs the reference population, 8.99; 95% CI, 8.61-9.39), which declined during the second year of follow-up (hazard ratio for stroke vs the reference population, 1.93; 95% CI, 1.85-2.08). Significant risk factors for depression for patients with stroke and the reference population included older age, female sex, single cohabitation status, basic educational attainment, diabetes, high level of somatic comorbidity, history of depression, and stroke severity (in patients with stroke). The associations were strongest for the reference population. In both populations, depressed individuals, especially those with new onset, had increased all-cause mortality (hazard ratio for new-onset depression, 1.89 [95% CI, 1.83-1.95] for patients with stroke and 3.75 [95% CI, 3.51-4.00] for the reference population) after adjustment for confounders. Similar patterns were found for natural and unnatural causes of death. In most models, the depression-related relative mortality was approximately twice as high in the reference population vs the stroke population. CONCLUSIONS AND RELEVANCE: Depression is common in patients with stroke during the first year after diagnosis, and those with prior depression or severe stroke are especially at risk. Because a large number of deaths can be attributable to depression after stroke, clinicians should be aware of this risk.

Entities:  

Year:  2016        PMID: 27603000     DOI: 10.1001/jamapsychiatry.2016.1932

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  32 in total

1.  Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients.

Authors:  Ida Kim Wium-Andersen; Marie Kim Wium-Andersen; Martin Balslev Jørgensen; Merete Osler
Journal:  J Psychiatry Neurosci       Date:  2017-09       Impact factor: 6.186

2.  Vascular Pathology and Trajectories of Late-Life Major Depressive Disorder in Secondary Psychiatric Care.

Authors:  Katherine L Musliner; Peter P Zandi; Xiaoqin Liu; Thomas M Laursen; Trine Munk-Olsen; Preben B Mortensen; William W Eaton
Journal:  Am J Geriatr Psychiatry       Date:  2017-07-12       Impact factor: 4.105

Review 3.  Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.

Authors:  Hannah J Roeder; Jean Rodriguez Lopez; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

4.  Stroke in young adults: Five new things.

Authors:  Nirav Bhatt; Amer M Malik; Seemant Chaturvedi
Journal:  Neurol Clin Pract       Date:  2018-12

5.  Interventions for management of post-stroke depression: A Bayesian network meta-analysis of 23 randomized controlled trials.

Authors:  Linghui Deng; Xuejun Sun; Shi Qiu; Yao Xiong; Yuxiao Li; Lu Wang; Qiang Wei; Deren Wang; Ming Liu
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

6.  Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.

Authors:  Yefei Sun; Yifan Liang; Yang Jiao; Jueying Lin; Huiling Qu; Junjie Xu; Chuansheng Zhao
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

7.  Pharmacological and psychotherapeutic interventions for management of poststroke depression: A Bayesian network meta-analysis of randomized controlled trials.

Authors:  Xuejun Sun; Linghui Deng; Shi Qiu; Xiang Tu; Deren Wang; Ming Liu
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  Prevalence and influencing factors of chronic post-traumatic stress disorder in patients with myocardial infarction, transient ischemic attack (TIA) and stroke - an exploratory, descriptive study.

Authors:  Aurora Dollenberg; Sebastian Moeller; Caroline Lücke; Ruihao Wang; Alexandra P Lam; Alexandra Philipsen; Jürgen M Gschossmann; Falk Hoffmann; Helge H O Müller
Journal:  BMC Psychiatry       Date:  2021-06-07       Impact factor: 3.630

9.  Factors that influence the severity of post-stroke depression.

Authors:  S Ilut; A Stan; A Blesneag; V Vacaras; S Vesa; L Fodoreanu
Journal:  J Med Life       Date:  2017 Jul-Sep

10.  Occurence of Post-Traumatic Stress Symptoms, Anxiety and Depression in the Acute Phase of Transient Ischemic Attack and Stroke.

Authors:  Helge H O Müller; Jürgen M Gschossmann; Katharina Czwalinna; Ruihao Wang; Caroline Lücke; Alexandra P Lam; Alexandra Philipsen; Sebastian Moeller
Journal:  Psychiatr Q       Date:  2021-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.